Ep 62: Tove Fall, the microbiome & study design. The vaginal resistome. Metallo-beta-lactamase inhibitors.
Happy start of the summer, dear listeners! In this episode before our break, we interview Professor Tove Fall, a veterinarian turned epidemiologist working to unveil the molecular connections determining health and sickness. We learn about her path, how she developed her career to fit her interests and strong skills, and how important study design is.
In the news section we cover a recent review about the vaginal microbiota, and a publication from one of our PhD students, who has been working on developing a new kind of inhibitor for metallo beta lactamases. We hope you enjoy this episode!
You can follow us and subscribe to our podcast to get new episodes directly in your preferred device and platform:
Relevant links:
- Prof. Tove Fall's profile site at Uppsala University.
- The SCAPIS cohort, mentioned during the intervew.
Further Reading:
- Antibiotic use in the past 8 years and gut microbiota composition. Recent pre-print by Tove Fall's group.
- Leveraging the microbiome to combat antibiotic resistant gynecological infections. First publication covered in the news section.
- Dynamically chiral phosphonic acid-type metallo-β-lactamase inhibitors. Second publication covered in the news section.
If you have any comments and suggestions you can email us here, or tweet to us (@UAC_UU) using the hashtag #theAMRStudio.